glp 1 risks long term GLP-1 has changed the conversation around weight loss—but it's important to understand what it can and cannot do. It's not the right choice for everyone, and it's not a replacement for healthy Analysis: GLP-1s and Mortality Risk

At temperatures above 20C for weeks or months, even lyophilized peptides can experience measurable degradation

Countries across the world are witnessing a surge in demand, particularly for drugs like semaglutide, which are widely used for weight loss

GlyNAC is a supplement that combines two amino acids: Glycine and N-Acetylcysteine (NAC)

Choline bitartrate and inositol meet USP monograph standards

GLP-1-H24-4 (Phase Ib) Results GLP-1-H24-4 Trial Design GLP-1-H24-4 was conducted with 24-25 overweight, obese, pre- or type 2 diabetic patients in each of the five study arms (n=126), of which 4 arms evaluated various DehydraTECH formulations with the 5th being the Study control arm

In clinical studies, higher levels of circulating long- and medium-chain acylcarnitines showed mixed results in patients with Alzheimers disease [24, 25] whereas clinical trials of patients with Parkinsons disease have consistently shown that circulating levels of long-chain acylcarnitines are decreased [26,27,28]